JP2024540172A5 - - Google Patents
Info
- Publication number
- JP2024540172A5 JP2024540172A5 JP2024525619A JP2024525619A JP2024540172A5 JP 2024540172 A5 JP2024540172 A5 JP 2024540172A5 JP 2024525619 A JP2024525619 A JP 2024525619A JP 2024525619 A JP2024525619 A JP 2024525619A JP 2024540172 A5 JP2024540172 A5 JP 2024540172A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- compound
- formula
- item
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163274389P | 2021-11-01 | 2021-11-01 | |
| US63/274,389 | 2021-11-01 | ||
| PCT/US2022/048401 WO2023076665A1 (en) | 2021-11-01 | 2022-10-31 | Methods for treating cardiovascular conditions and methods of increasing the efficiency of cardiac metabolism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540172A JP2024540172A (ja) | 2024-10-31 |
| JP2024540172A5 true JP2024540172A5 (https=) | 2025-10-16 |
Family
ID=86158627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525619A Pending JP2024540172A (ja) | 2021-11-01 | 2022-10-31 | 心血管状態を処置するための方法および心臓の代謝効率を増大させる方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250235447A1 (https=) |
| EP (1) | EP4426301A4 (https=) |
| JP (1) | JP2024540172A (https=) |
| KR (1) | KR20240095326A (https=) |
| CN (1) | CN118647381A (https=) |
| AU (1) | AU2022376557A1 (https=) |
| CA (1) | CA3236328A1 (https=) |
| IL (1) | IL312523A (https=) |
| WO (1) | WO2023076665A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025054580A1 (en) * | 2023-09-08 | 2025-03-13 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Compositions and methods for increasing myocardial capillary formation, reducing left ventricular hypertrophy and/or reducing ventricular dysfunction |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL283725B2 (en) * | 2017-06-20 | 2024-04-01 | Imbria Pharmaceuticals Inc | Compositions and methods for increasing efficiency of cardiac metabolism |
| TWI683808B (zh) * | 2017-07-18 | 2020-02-01 | 德商菲尼克斯 Ｆｘｒ有限責任公司 | 含有胺或(硫)醯胺之lxr調節劑 |
| EP3976103A4 (en) * | 2019-05-31 | 2023-06-28 | Imbria Pharmaceuticals, Inc. | Methods of altering cardiac remodeling using compounds that promote glucose oxidation |
-
2022
- 2022-10-31 US US18/703,512 patent/US20250235447A1/en active Pending
- 2022-10-31 CN CN202280085857.0A patent/CN118647381A/zh active Pending
- 2022-10-31 AU AU2022376557A patent/AU2022376557A1/en active Pending
- 2022-10-31 KR KR1020247018009A patent/KR20240095326A/ko active Pending
- 2022-10-31 WO PCT/US2022/048401 patent/WO2023076665A1/en not_active Ceased
- 2022-10-31 IL IL312523A patent/IL312523A/en unknown
- 2022-10-31 EP EP22888285.8A patent/EP4426301A4/en active Pending
- 2022-10-31 JP JP2024525619A patent/JP2024540172A/ja active Pending
- 2022-10-31 CA CA3236328A patent/CA3236328A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rosei et al. | Metabolic profile of nebivolol, a β-adrenoceptor antagonist with unique characteristics | |
| JP2021523103A5 (https=) | ||
| JP2021535164A5 (https=) | ||
| JP2025131625A5 (https=) | ||
| JP2019531320A5 (https=) | ||
| JP2018508569A5 (https=) | ||
| JP2024508526A5 (https=) | ||
| JP2023100919A5 (https=) | ||
| NO20045557L (no) | Kombinasjon av en DPP IV inhibitor og en kardiovaskulaer forbindelse | |
| JP2024540172A5 (https=) | ||
| JP2023550444A5 (https=) | ||
| JP2021529185A5 (https=) | ||
| HRP20250931T1 (hr) | Pripravak za upotrebu u postupku liječenja prekomjerne težine i pretilosti kod pacijenata s visokim kardiovaskularnim rizikom | |
| JP2020511502A5 (https=) | ||
| JP2020523327A5 (https=) | ||
| JP2024501764A5 (https=) | ||
| JP2022535195A5 (https=) | ||
| JP2023529502A5 (https=) | ||
| JP2020111571A5 (https=) | ||
| JP2016522196A5 (https=) | ||
| JP2024517769A5 (https=) | ||
| Allencherril et al. | Heart failure in thyrotoxic cardiomopathy: extracorporeal membrane oxygenation treatment for Graves’ disease | |
| Jazwiec et al. | Right ventricular free wall stress after tricuspid valve annuloplasty in acute ovine right heart failure | |
| JP7535373B2 (ja) | 肝硬変の治療のための組成物 | |
| JP2023531802A5 (https=) |